Cargando…

Long-term safety and immunogenicity of the M72/AS01(E) candidate tuberculosis vaccine in HIV-positive and -negative Indian adults: Results from a phase II randomized controlled trial

OBJECTIVES: To assess the long-term safety and immunogenicity of the M72/ Adjuvant System (AS01(E)) candidate tuberculosis (TB) vaccine up to 3 years post-dose 2 (Y3) in human immunodeficiency virus (HIV)-positive (HIV+) and HIV-negative (HIV−) Indian adults. METHODS: This phase II, double-blind, ra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumarasamy, Nagalingeswaran, Poongulali, Selvamuthu, Beulah, Faith Esther, Akite, Elaine Jacqueline, Ayuk, Leo Njock, Bollaerts, Anne, Demoitié, Marie-Ange, Jongert, Erik, Ofori-Anyinam, Opokua, Van Der Meeren, Olivier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250513/ https://www.ncbi.nlm.nih.gov/pubmed/30407329 http://dx.doi.org/10.1097/MD.0000000000013120

Ejemplares similares

A Randomized, Controlled Safety, and Immunogenicity Trial of the M72/AS01 Candidate Tuberculosis Vaccine in HIV-Positive Indian Adults
por: Kumarasamy, Nagalingeswaran, et al.
Publicado: (2016)

A Randomized, Controlled Dose-Finding Phase II Study of the M72/AS01 Candidate Tuberculosis Vaccine in Healthy PPD-Positive Adults
por: Montoya, Jaime, et al.
Publicado: (2013)

Safety and immunogenicity of candidate vaccine M72/AS01(E) in adolescents in a TB endemic setting
por: Penn-Nicholson, Adam, et al.
Publicado: (2015)

Impact of COVID-19 on people living with HIV: A review
por: Prabhu, Sandeep, et al.
Publicado: (2020)

Phase 2b placebo-controlled trial of M72/AS01(E) candidate vaccine to prevent active tuberculosis in adults
por: Van Der Meeren, Olivier, et al.
Publicado: (2018)

Prevalence and factors associated with renal dysfunction in patients on tenofovir disoproxil fumarate-based antiretroviral regimens for HIV infection in Southern India
por: Kumarasamy, Nagalingeswaran, et al.
Publicado: (2018)

120. A Randomized Double-blind Trial Assessing the Efficacy of M72/AS01(E) Vaccine Against Pulmonary Tuberculosis Disease in Adults With Latent Mycobacterium tuberculosis Infection
por: Meeren, Olivier Van Der, et al.
Publicado: (2018)

A Phase IIa Controlled Human Malaria Infection and Immunogenicity Study of RTS,S/AS01(E) and RTS,S/AS01(B) Delayed Fractional Dose Regimens in Malaria-Naive Adults
por: Moon, James E, et al.
Publicado: (2020)

Evaluation of RTS,S/AS02A and RTS,S/AS01B in Adults in a High Malaria Transmission Area
por: Polhemus, Mark E., et al.
Publicado: (2009)

Immune correlates of cardiovascular co-morbidity in HIV infected participants from South India
por: Kausalya, Bagavathi, et al.
Publicado: (2022)

Immunogenicity and safety of Southern Hemisphere inactivated quadrivalent influenza vaccine: a Phase III, open-label study of adults in Brazil
por: Zerbini, Cristiano A.F., et al.
Publicado: (2016)

Cardiac morbidity in HIV infection is associated with checkpoint inhibitor LAG-3 on CD4 T cells
por: Pallikkuth, Suresh, et al.
Publicado: (2018)

Ocular syphilis in patients with human immunodeficiency virus/acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy
por: Sudharshan, Sridharan, et al.
Publicado: (2020)

Design of a phase III multicenter trial to evaluate the efficacy of the RTS,S/AS01 malaria vaccine in children across diverse transmission settings in Africa
por: Leach, Amanda, et al.
Publicado: (2011)

A Randomized Trial Assessing the Safety and Immunogenicity of AS01 and AS02 Adjuvanted RTS,S Malaria Vaccine Candidates in Children in Gabon
por: Lell, Bertrand, et al.
Publicado: (2009)

Efficacy of RTS,S/AS01(E) malaria vaccine administered according to different full, fractional, and delayed third or early fourth dose regimens in children aged 5–17 months in Ghana and Kenya: an open-label, phase 2b, randomised controlled trial
por: Samuels, Aaron M, et al.
Publicado: (2022)

Isolated cortical blindness without simultaneous neurological involvement in progressive multifocal leukoencephalopathy in a patient with human immune deficiency virus infection
por: Jeyaraman, Vijay Ananth, et al.
Publicado: (2013)

Immunogenicity and Safety of the M72/AS01(E) Candidate Vaccine Against Tuberculosis: A Meta-Analysis
por: Ji, Zhenhua, et al.
Publicado: (2019)

Subsequent AS01-adjuvanted vaccinations induce similar transcriptional responses in populations with different disease statuses
por: Coccia, Margherita, et al.
Publicado: (2022)

Randomized Controlled Trial of RTS,S/AS02(D) and RTS,S/AS01(E) Malaria Candidate Vaccines Given According to Different Schedules in Ghanaian Children
por: Owusu-Agyei, Seth, et al.
Publicado: (2009)

Correction: Randomized Controlled Trial of RTS,S/AS02(D) and RTS,S/AS01(E) Malaria Candidate Vaccines Given According to Different Schedules in Ghanaian Children
por: Owusu-Agyei, Seth, et al.
Publicado: (2010)

The Synthetic Plasmodium falciparum Circumsporozoite Peptide PfCS102 as a Malaria Vaccine Candidate: A Randomized Controlled Phase I Trial
por: Audran, Régine, et al.
Publicado: (2009)

Efficacy and Safety of Tenofovir Disoproxil Fumarate Versus Low-Dose Stavudine Over 96 Weeks: A Multicountry Randomized, Noninferiority Trial
por: Venter, Willem Daniel Francois, et al.
Publicado: (2019)

Sequence conservation analysis and in silico human leukocyte antigen-peptide binding predictions for the Mtb72F and M72 tuberculosis candidate vaccine antigens
por: Mortier, Marie-Cécile, et al.
Publicado: (2015)

The Systematic Review and Meta-Analysis on the Immunogenicity and Safety of the Tuberculosis Subunit Vaccines M72/AS01(E) and MVA85A
por: Ullah, Inayat, et al.
Publicado: (2020)

Safety and immunogenicity of the RTS,S/AS01 malaria vaccine in infants and children identified as HIV-infected during a randomized trial in sub-Saharan Africa
por: Otieno, Lucas, et al.
Publicado: (2020)

Triple trouble: A case of retinochoroiditis in a patient with syphilis, tuberculosis, and human immunodeficiency virus infection
por: Latif, Neethu, et al.
Publicado: (2020)

Seasonal malaria vaccination: protocol of a phase 3 trial of seasonal vaccination with the RTS,S/AS01(E) vaccine, seasonal malaria chemoprevention and the combination of vaccination and chemoprevention
por: Chandramohan, Daniel, et al.
Publicado: (2020)

Validation of an enzyme-linked immunosorbent assay for the quantification of human IgG directed against the repeat region of the circumsporozoite protein of the parasite Plasmodium falciparum
por: Clement, Frederic, et al.
Publicado: (2012)

Induction of Plasmodium falciparum-Specific CD4(+) T Cells and Memory B Cells in Gabonese Children Vaccinated with RTS,S/AS01(E) and RTS,S/AS02(D)
por: Agnandji, Selidji T., et al.
Publicado: (2011)

Simultaneous presentation of ocular surface squamous neoplasia with viral retinitis in HIV-positive patients with low CD4 counts
por: Rajagopal, Rama, et al.
Publicado: (2019)

Immunogenicity and safety of the AS04-HPV-16/18 and HPV-6/11/16/18 human papillomavirus vaccines in asymptomatic young women living with HIV aged 15–25 years: A phase IV randomized comparative study
por: Folschweiller, Nicolas, et al.
Publicado: (2020)

Adjuvant-Associated Peripheral Blood mRNA Profiles and Kinetics Induced by the Adjuvanted Recombinant Protein Candidate Tuberculosis Vaccine M72/AS01 in Bacillus Calmette–Guérin-Vaccinated Adults
por: van den Berg, Robert A., et al.
Publicado: (2018)

Challenges and lessons learned from four years of planning and implementing pharmacovigilance enhancement in sub-Saharan Africa
por: Stegmann, Jens-Ulrich, et al.
Publicado: (2022)

Pediatric multi-drug resistant-tuberculosis and HIV co-infection in a resource—limited setting: a case report
por: Jouego, Christelle Géneviève, et al.
Publicado: (2018)

The Anti-Circumsporozoite Antibody Response of Children to Seasonal Vaccination With the RTS,S/AS01(E) Malaria Vaccine( )
por: Sagara, Issaka, et al.
Publicado: (2021)

Protective Immunity Induced with the RTS,S/AS Vaccine Is Associated with IL-2 and TNF-α Producing Effector and Central Memory CD4(+) T Cells
por: Lumsden, Joanne M., et al.
Publicado: (2011)

Real-time polymerase chain reaction for diagnosis and management of HIV-induced uveitis
por: Selvaraj, Jayapratha R, et al.
Publicado: (2018)

Enhancing Pharmacovigilance in Sub-Saharan Africa Through Training and Mentoring: A GSK Pilot Initiative in Malawi
por: Jusot, Viviane, et al.
Publicado: (2020)

Correction to: Enhancing Pharmacovigilance in Sub-Saharan Africa Through Training and Mentoring: A GSK Pilot Initiative in Malawi
por: Jusot, Viviane, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v93nq1c0o37f8u7b5na1rpr4f4